Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/3f7a346c-3eeb-48fe-8064-da6220a71504/
VIT
Vitura Health LimitedSnapshot 2026-07-19 · 0.6w · Fresh
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
30.7%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
Yes
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
21.0%ile
P/E
6.2×
P/S
0.2×
P/B
0.4×
E/P
0.2053
FCF Yield
-0.072
EBITDA/EV
0.307
SH Yield
-0.186
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
80.00000000
/100 — 1=cheapest
VC2 (Trending Value)
79.00000000
/100
VC3 (Buyback)
79.00000000
/100
P/E of 6.2x places this firmly in deep value territory. Negative FCF yield (-7.2%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
19.0%ile
ROE
0.069
ROA
0.044
Net Margin
0.027
Op Margin
0.042
GPA
0.447
Current
1.37
F-Score
2/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.001
Earn Growth
-0.177
5yr Consist
No
F-Score of 2/9 flags fundamental deterioration — multiple signals are weakening.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
20.0%ile
6M Return
-47.5%
12M Return
-53.1%
12-1 Mom
-56.1%
Risk-Adj
-1.08
Vol 252d
51.9%
Vol 60d
124.0%
↑ Expanding
Max DD 12M
-69.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -56% signals a downtrend — price is moving against you. Near-term vol (124%) is expanding vs long-term (52%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.07
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 145 peers
Sector Value %ile
26.0%
Sector Quality %ile
24.0%
P/E z-score
-0.54
P/B z-score
-0.56
Sector Avg OS
45.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (124%) significantly exceeds 252-day (52%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
71.1% avg (7 factors)
Quality
D
36.3% avg (6 factors)
Momentum
F
0.0% avg (4 factors)
Risk
D
30.2% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.070 | —4 | — | |
| Value %ile | 0.210 | —4 | — | |
| Quality %ile | 0.190 | —4 | — | |
| Momentum %ile | 0.200 | —4 | — | |
| F-Score | 2.000 | —7 | — | |
| Confidence | 0.460 | —0 | — | |
| Volatility | 0.519 | —4 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
6.18
Earnings Yield (E/P)
0.2053
Price / Sales
0.17
Price / Book
0.43
FCF Yield
-7.2%
EBITDA / EV
30.7%
Sales Yield (1/P·S)
4.8572
Shareholder Yield
Div + net buyback / mktcap
-18.6%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
6.9%
Return on Assets
4.4%
Net Margin
2.7%
Operating Margin
4.2%
Gross Profit / Assets
Novy-Marx GPA
44.7%
Current Ratio
1.37
External Financing
Net issuance — lower=better
0.069
MomentumPrice trend strength over different horizons
6M Return
-47.5%
12M Return
-53.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-56.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-1.08
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
0.1%
Earnings Growth (YoY)
-17.7%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
2
Dividend Yield
6.5%
Buyback Yield
-25.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
80
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
79
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
79
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity